About Neurotype
Neurotype is a company based in Minneapolis (United States) founded in 2019 by Scott Burwell. Neurotype offers products and services including NeuromarkR™ Platform. Neurotype operates in a competitive market with competitors including Pivot, Chrono Therapeutics, e-Nicotine Technology, Velectron labs and Lana Exprience, among others.
- Headquarter Minneapolis, United States
- Founders Scott Burwell
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Neurotype Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$328.96 K (USD), Grant
Sep 30, 2023
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Neurotype
Neurotype offers a comprehensive portfolio of products and services, including NeuromarkR™ Platform.
Device for monitoring and managing triggers in substance use recovery.
Funding Insights of Neurotype
Investors in Neurotype
Neurotype has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Neurotype
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Neurotype
Investment portfolio details for Neurotype
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Neurotype
Detailed financials for Neurotype
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Neurotype Comparisons
Peer comparison for Neurotype
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Neurotype
Neurotype operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pivot, Chrono Therapeutics, e-Nicotine Technology, Velectron labs and Lana Exprience, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital health solutions for tobacco cessation are provided by Pivot.
|
|
| Locked | Locked | Locked |
Develops transdermal nicotine replacement therapy for smoking cessation.
|
|
| Locked | Locked | Locked |
Nicotine Delivery with e-health tools to help individuals transition from smoking.
|
|
| Locked | Locked | Locked |
Wearable anti-addiction devices are developed for customer support.
|
|
| Locked | Locked | Locked |
Offers smart solutions for individuals dealing with substance use disorders.
|
Detailed competitors of Neurotype
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Neurotype
Complete news archive for Neurotype
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Neurotype
Neurotype was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Neurotype is headquartered in Minneapolis, United States. It is registered at Minneapolis, Minnesota, United States.
Scott Burwell is the current CEO of Neurotype. They have also founded this company.
Neurotype was founded in 2019 in Minneapolis, United States, within the neurotechnology sector. Brain sensors and digital therapeutics are being developed to support treatment of craving in drug and food addictions. Neurofeedback systems and related tools are offered to identify and manage triggers. Operations center on advancing addiction therapies through sensor-based interventions and digital platforms.
Neurotype's top competitors include Pivot, e-Nicotine Technology and Velectron labs.
Neurotype offers NeuromarkR™ Platform.
Neurotype has 1 investor. Key investors include HHS.